United States HR 5039: Life-Sustaining Prescription Drug Price Relief Act of 2019

Status: Sponsor introductory remarks on measure. (CR H8836) (as of 2019-11-14)

State: United States · Session: 116 · Bill: HR 5039

Subjects: Asia, Business records, Canada, Civil actions and liability, Congressional oversight, Department of Health and Human Services, Europe, France, Germany, Government information and archives, Government trust funds, Health care costs and insurance, Health information and medical records, Inflation and prices, Japan, Manufacturing, Marketing and advertising, Medical research, Medicare, North America, Prescription drugs, Research and development, United Kingdom

Sponsors: Daniel William Lipinski

View United States HR 5039 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.